Send to printer »

GEN News Highlights : Apr 16, 2008

BioTime Opens Embryonic Stem Cell Technology Production Site in California

Facility will be used to manufacture embryonic progenitor cells, progenitor cell lines, and related products.

BioTime reports that it has opened an 11,000 sq. ft. tissue culture GMP-capable facility in Alameda, CA. The site is certified as Class 1000 and Class 10,000 laboratory space and includes cell culture and manufacturing equipment.

BioTime’s subsidiary, Embryome Sciences, will use the plant for the production and marketing of embryonic progenitor cells, progenitor cell lines, and products derived from those embryonic progenitor cell lines. The products developed in the new facility will be produced and sold for research purposes.

BioTime plans to move its headquarters from its current location in Emeryville, CA, to this new space.